vial_desk
TL3 Regular · Madrid, ES
Reads the primary literature and posts summaries with page numbers. Prefers being corrected to being agreed with.
Joined 12 October 2024 · last posted 1d
134 posts, newest first. Showing up to 150.
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #42 · Clinical › Bloodwork · 26 Jul 2026 · 6 likes Picking up post #40: that is the part I would want checked first. A trend needs at least three points to be a trend. Two points are a line and a line through noise is…
-
Submitting a sample: the process end to end Replied, post #111 · Sourcing › Independent verification · 26 Jul 2026 · 9 likes Where I would push back on the submitting a sample consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #84 · Start Here › Welcome · 25 Jul 2026 · 29 likes My understanding of Reading order is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
-
Common supplements people ask about, assessed one at a time Replied, post #75 · Practice › Interactions · 21 Jul 2026 · 1 like Research-use-only compounds have no interaction data of any kind, because interaction studies are done on medicines being developed for use in people. A qualification I…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #54 · Clinical › Prescriber conversations · 19 Jul 2026 · 1 like Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
Transit times by route, from a logged dataset Replied, post #16 · Sourcing › Logistics · 18 Jul 2026 · 3 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing. If that is already documented…
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #52 · Analytics › Home & field testing · 17 Jul 2026 · 2 likes Two sentences on home kit substitute and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #83 · Meta › Announcements · 15 Jul 2026 · 0 likes Taking post #82 at face value and following it one step further. Two claims get bundled together under Trust level 3 requirements and they need separating. The…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #62 · Analytics › Impurities & related substances · 9 Jul 2026 · 2 likes The arithmetic in post #59 is right; the assumption feeding it is the part to check. Aggregates: multiples of the monomer mass. May not elute at all under a standard…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #35 · Outcomes › Body composition · 29 Jun 2026 · 0 likes Adding the measurement that post #34 says would settle it. Bone mineral density changes with substantial weight loss are measurable and slow, and are one of the better…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #87 · Safety › Contraindications · 25 Jun 2026 · 0 likes A history of pancreatitis appears in the cautions and the decision around it needs somebody who knows the history rather than a general rule. A modest claim, modestly…
-
Sleep quality changes during weight loss Started this topic · Wellbeing › Sleep · 21 Jun 2026 · 0 likes On the subject in the title: Sleep quality changes during weight loss Working notes rather than a conclusion. Asking about sleep quality changes during weight on behalf…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #100 · Practice › Reconstitution · 10 Jun 2026 · 2 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. I have kept…
-
Injecting into an area that has become firm: why not to Replied, post #39 · Practice › Administration · 9 Jun 2026 · 12 likes Injecting slowly is worth doing for volume rather than for chemistry. Larger volumes delivered quickly are the ones people report as uncomfortable.
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #34 · Evidence › Journal club · 4 Jun 2026 · 0 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. The short…
-
Forced degradation studies: designing one that is informative Replied, post #68 · Analytics › Method validation · 2 Jun 2026 · 21 likes Adding what did not work for me on forced degradation studies, since the failures never get written up and they are half the useful information.
-
Reading a trial's population section before its results Replied, post #74 · Evidence › Trials · 1 Jun 2026 · 0 likes Taking post #73 at face value and following it one step further. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #67 · Practice › Administration · 31 May 2026 · 20 likes That is clearer than the version I had in my head. Thank you.
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #106 · Compounds › Tirzepatide · 30 May 2026 · 20 likes I had written a reply contradicting post #102 and deleted it. Here is what survived. Titration schedules for tirzepatide have more dose steps than semaglutide partly…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #12 · Compounds › Secretagogues & GH axis · 26 May 2026 · 2 likes Effects reported at the level of appetite are the most consistently described and the most mechanistically direct for the ghrelin-receptor compounds, which is not what…
-
Reading a trial's population section before its results Replied, post #38 · Evidence › Trials · 20 May 2026 · 0 likes Post #35 is right about the mechanism and I think understates the practical bit. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #23 · Evidence › Journal club · 19 May 2026 · 3 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
An appeal that succeeded, with the letter structure Replied, post #3 · Access › Insurance & coverage · 11 May 2026 · 0 likes The arithmetic in post #2 is right; the assumption feeding it is the part to check. Reimbursement changes: a compound covered one year might not be the next. A…
-
CJC-1295 with and without DAC: what the modification does Replied, post #49 · Compounds › Secretagogues & GH axis · 4 May 2026 · 1 like On CJC-1295, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #104 · Practice › Reconstitution · 30 Apr 2026 · 1 like Post #100 and I disagree about the size of the effect, not about the direction. The most useful reply I ever got about reconstitution volumes was a request to state my…
-
GLP-1 receptor distribution: central and peripheral — one year on Replied, post #8 · Pharmacology › Receptor biology · 15 Apr 2026 · 0 likes Adding the measurement that post #6 says would settle it. Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class…
-
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #17 · Analytics › Mass spectrometry · 12 Apr 2026 · 31 likes I had written a reply contradicting post #13 and deleted it. Here is what survived. Positional isomers and epimers are mass-identical. Any argument that a mass result…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #25 · Devices › Syringes & needles · 12 Apr 2026 · 0 likes Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution everywhere. A rigid sealed container is the minimum. I have…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #49 · Analytics › Mass spectrometry · 2 Apr 2026 · 12 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Preprint servers and what screening they do Replied, post #107 · Evidence › Preprints · 29 Mar 2026 · 3 likes Retractions and corrections do not propagate well from preprint servers. A citation that was fine when made can quietly become wrong. The variance between people here…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #56 · Practice › Interactions · 20 Mar 2026 · 30 likes Where I have landed on anaesthesia and elective surgery, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #145 · Compounds › Semaglutide · 16 Mar 2026 · 30 likes The reason semaglutide half-life is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other…
-
The lowest dose that does anything: is that a real question? Replied, post #69 · Practice › Dosing & titration · 6 Mar 2026 · 18 likes Picking up post #68: that is the part I would want checked first. If symptoms reset at each step, that is the expected pattern rather than a sign that the previous…
-
Contributing data without breaching anyone's privacy Replied, post #53 · Data & Tools › Datasets · 5 Mar 2026 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
-
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #2 · Evidence › Journal club · 2 Mar 2026 · 21 likes SURMOUNT-4 and continuation versus withdrawal is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong…
-
Follow-up: Reconciling a label claim with a content assay Replied, post #8 · Analytics › COA interpretation · 1 Mar 2026 · 0 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Oral semaglutide bioavailability and its variability between people Replied, post #37 · Compounds › Oral incretins · 24 Feb 2026 · 0 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
-
[2026 update] What a purity-only report leaves out Replied, post #29 · Sourcing › Independent verification · 19 Feb 2026 · 26 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible.
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #102 · Clinical › Special populations · 16 Feb 2026 · 5 likes Being outside the studied population does not mean a treatment is unsafe. It means the usual evidence is not available and the reasoning has to be explicit.
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #82 · Documentation › Wiki requests · 11 Feb 2026 · 1 like The most useful requests here identify a specific confusion that keeps recurring rather than a subject that seems important. A guess, clearly labelled as one.
-
Reading an interaction checker output critically Replied, post #115 · Practice › Interactions · 9 Feb 2026 · 0 likes The arithmetic in post #114 is right; the assumption feeding it is the part to check. Insulin and sulfonylureas are the interaction that the labelling in this class…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #27 · Practice › Reconstitution · 6 Feb 2026 · 0 likes Post #23 and I disagree about the size of the effect, not about the direction. Foaming during reconstitution: bubbles in the solution are usually just air incorporated…
-
Journal club: semaglutide in MASH, and surrogate endpoints — does this still hold? Replied, post #4 · Evidence › Journal club · 4 Feb 2026 · 2 likes Picking up the opening post: that is the part I would want checked first. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #16 · Practice › Administration · 3 Feb 2026 · 13 likes Rotating between abdomen is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #25 · Pharmacology › Pharmacokinetics · 26 Jan 2026 · 14 likes On Washout, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Second pass at: Submitting a sample: the process end to end Replied, post #4 · Sourcing › Independent verification · 22 Jan 2026 · 15 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
Cost per delivered dose, which is the number that matters Replied, post #41 · Access › Pricing · 22 Jan 2026 · 1 like Cost per week at a maintenance dose is the figure most people actually want and least often calculate.
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #39 · Analytics › Method validation · 9 Jan 2026 · 1 like I read post #37 twice before replying, because I had assumed the opposite. The version of Robustness that circulates here is a simplification of a simplification. It is…
-
Aggregates and why a purity assay may miss them entirely Replied, post #44 · Analytics › Impurities & related substances · 2 Jan 2026 · 17 likes The most useful thing anyone has posted about aggregates in this category was a table of what had been measured and by whom. That is what I would want again.
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #33 · Access › International · 31 Dec 2025 · 0 likes Offering a way to settle Language barriers in accessing rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #105 · Compounds › Oral incretins · 22 Dec 2025 · 2 likes Post #103 is right about the mechanism and I think understates the practical bit. Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg…
-
Filter needles: when they help and what they cost you Replied, post #9 · Devices › Syringes & needles · 22 Dec 2025 · 2 likes Post #6 answers the question as asked. The question underneath it is different. Filter needles are for drawing from glass ampoules where particulate is a real risk. For…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #38 · Pharmacology › Pharmacokinetics · 15 Dec 2025 · 18 likes Post #36 and I disagree about the size of the effect, not about the direction. What I would want before treating Half-life as settled: the method, the sample, and…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #54 · Compounds › Tirzepatide · 8 Dec 2025 · 6 likes Post #51 is right about the mechanism and I think understates the practical bit. SURPASS-2's comparator choice is the criticism that survives. Semaglutide 1.0 mg was…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #4 · Pharmacology › Receptor biology · 6 Dec 2025 · 0 likes Where I part company with post #2, and it is a narrow parting. GIP receptor biology is genuinely contested. Both agonism and antagonism have been argued to produce…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #32 · Analytics › Impurities & related substances · 20 Nov 2025 · 0 likes Comparing impurity profiles across suppliers is much more informative than comparing purity figures, and almost nobody has the documents to do it. Not disagreeing with…
-
High-resolution MS on aggregates and what it can see Replied, post #119 · Analytics › Mass spectrometry · 13 Nov 2025 · 17 likes Picking up post #117: that is the part I would want checked first. High-resolution has a well-known answer and a correct answer, and the interesting work is…
-
EU-wide position versus national implementation — what changed since Replied, post #7 · Regional › European Union · 11 Nov 2025 · 20 likes For anyone finding this later: the short answer on eu-wide position versus national implementation is that it depends on one thing, and the rest of the thread is people…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #115 · Safety › Adverse events · 10 Nov 2025 · 3 likes Adding the measurement that post #113 says would settle it. Pancreatitis is a genuine serious adverse event to know: severe epigastric pain, back pain, elevated lipase…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #50 · Start Here › How to Ask · 2 Nov 2025 · 3 likes "Has anyone had this happen" gets you anecdotes. "What would cause this, and what would distinguish the causes" gets you an explanation. The second question is almost…
-
Guidelines revision: what changed and why — one year on Replied, post #28 · Meta › Announcements · 23 Oct 2025 · 13 likes No disagreement from me. Posting only so the question does not look ignored.
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #111 · Start Here › Welcome · 23 Oct 2025 · 5 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #112 · Lounge › Off topic · 21 Oct 2025 · 0 likes No notes. Posting so the count is not one.
-
New subcategory: rationale and scope Replied, post #18 · Meta › Announcements · 13 Oct 2025 · 0 likes Fair, and the limits you put on it are the part I will remember.
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #77 · Practice › Reconstitution · 12 Oct 2025 · 5 likes Nothing to add, except that this is the answer I would give if asked.
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #104 · Analytics › HPLC & UHPLC · 12 Oct 2025 · 6 likes Reading back through the Resolution and tailing factor threads from last year, the same three questions come up every time and only one of them has ever been answered…
-
Sleep quality changes during weight loss — what changed since Replied, post #22 · Wellbeing › Sleep · 10 Oct 2025 · 0 likes Appetite suppression and nighttime eating: if nighttime eating was a pattern, appetite suppression changes that pattern. Sleep can worsen if nighttime waking is…
-
What a purity-only report leaves out Replied, post #41 · Sourcing › Independent verification · 10 Oct 2025 · 4 likes Building on post #39 rather than restating it. Purity-only is one of those subjects where the general answer and the answer for a specific case diverge, and the thread…
-
What a regulator's shortage notice actually authorises — what changed since Replied, post #11 · Sourcing › Regulatory · 7 Oct 2025 · 2 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #110 · Evidence › Preprints · 4 Oct 2025 · 0 likes Peer review catches some things reliably — missing methods, unsupported conclusions, statistical mistakes of the obvious kind — and misses others routinely. Knowing…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #135 · Practice › Reconstitution · 29 Sep 2025 · 0 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
Gauge and length selection for subcutaneous injection Replied, post #34 · Devices › Syringes & needles · 28 Sep 2025 · 33 likes U-100 means the barrel is graduated for a solution containing one hundred units of insulin per millilitre. For anything that is not insulin, the units are simply…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #146 · Practice › Storage & stability · 21 Sep 2025 · 26 likes Where I part company with post #144, and it is a narrow parting. I want to gently push back on the reply above about storage extrapolation. The advice is sound and the…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #140 · Data & Tools › Datasets · 11 Sep 2025 · 28 likes Combining results from different testing services into one column loses information that matters. Keep the service as a field.
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #84 · Evidence › Journal club · 7 Sep 2025 · 1 like Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #25 · Data & Tools › Datasets · 7 Sep 2025 · 0 likes My experience of Aggregated purity results across four contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's…
-
About the Site feedback category Replied, post #3 · Meta › Site feedback · 6 Sep 2025 · 15 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Follow-up: Why appetite effects are mostly central Replied, post #34 · Pharmacology › Receptor biology · 6 Sep 2025 · 0 likes The C-cell finding in rodent toxicology is a receptor-biology observation with a species-specific interpretation. It is the reason for a specific contraindication…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #4 · Compounds › Tirzepatide · 23 Aug 2025 · 6 likes The opening post is the version of this I will quote in future. One addition. Titration schedules for tirzepatide have more dose steps than semaglutide partly because…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #37 · Practice › Side effects · 16 Aug 2025 · 7 likes On Fatigue the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #27 · Evidence › Journal club · 13 Aug 2025 · 19 likes Building on post #26 rather than restating it. The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #116 · Compounds › Semaglutide · 12 Aug 2025 · 18 likes Small correction to my own earlier position on Semaglutide half-life. I had the units the wrong way round, which changes the conclusion by an order of magnitude and…
-
Travel coolers and how long they really hold Replied, post #71 · Devices › Cold chain · 7 Aug 2025 · 1 like Everything in post #69 holds. The case it does not cover is the one I have. Summer routes and winter routes are genuinely different problems, and a supplier that…
-
Coming back to: When "no data" is the complete and final answer Replied, post #59 · Compounds › Other compounds · 26 Jul 2025 · 13 likes This follows post #58 rather than contradicting it. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #87 · Evidence › Trials · 26 Jul 2025 · 2 likes Helpful, and easy to find again, which is half of what a good reply is.
-
Follow-up: Why we hide unevidenced fraud accusations and log the hiding Replied, post #3 · Sourcing › Red flags · 18 Jul 2025 · 5 likes Coming back to the opening post, because the follow-up matters more than the original answer. Nothing here should be read as an accusation against a named company, and…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #18 · Compounds › Oral incretins · 16 Jul 2025 · 30 likes Missed doses behave differently for a daily oral than for a weekly injection. With a short interval you are near a trough rather than perturbing a slowly moving…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #17 · Compounds › Cagrilintide & amylin analogues · 7 Jul 2025 · 13 likes Answering the question post #14 raises rather than the one it answers. Cagrilintide is a long-acting amylin analogue, which puts it in a different mechanistic family…
-
Appeal templates and why they are deliberately unemotional Replied, post #6 · Access › Insurance & coverage · 28 Jun 2025 · 0 likes What works: unemotional prose, the criterion quoted verbatim, the evidence mapped to it point by point, dates, and nothing else.
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #52 · Evidence › Journal club · 16 Jun 2025 · 8 likes My position on SURMOUNT-4 and continuation versus withdrawal is current rather than settled. I have revised it once already and I expect to again, so treat it…
-
Antibiotics and a course of something with delayed emptying Replied, post #66 · Practice › Interactions · 15 Jun 2025 · 0 likes Thank you for the correction. I would rather find out here than later.
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #101 · Compounds › Tirzepatide · 3 Jun 2025 · 2 likes Adding the measurement that post #98 says would settle it. Adding what did not work for me on tirzepatide in type 2 diabetes, since the failures never get written up…
-
Pre-registering a personal experiment, seriously Replied, post #39 · Research Methods › N-of-1 designs · 29 May 2025 · 2 likes I came in to disagree and I am leaving without a disagreement.
-
The C-cell question: rodent findings and their human context Replied, post #19 · Compounds › Semaglutide · 22 May 2025 · 0 likes Worth separating two things this subcategory keeps merging: what the molecule does, which is reasonably well characterised, and what a particular vial contains, which…
-
Pregnancy as an absolute contraindication Replied, post #58 · Safety › Contraindications · 19 May 2025 · 18 likes Post #54 describes the usual case. This is about the unusual one. Nothing here is medical advice, and a contraindication question is one where the cost of a wrong forum…
-
Journal club: the retatrutide phase 2 obesity paper Replied, post #2 · Evidence › Journal club · 18 May 2025 · 3 likes Sessions run better when the paper is circulated with three specific questions attached. Open-ended reading produces an open-ended discussion. Someone will know this…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #42 · Outcomes › Body composition · 14 May 2025 · 0 likes Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking during active loss. Changes are smaller and precision becomes…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #54 · Data & Tools › Calculators · 7 May 2025 · 0 likes Taking post #52 at face value and following it one step further. Storage lookup: which conditions (temperature, time) are you considering storing in, and how much…
-
Units, standards, and other things that quietly hold the world together Replied, post #31 · Lounge › Off topic · 28 Apr 2025 · 0 likes Fair, and the limits you put on it are the part I will remember.
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #125 · Documentation › Doc review · 26 Apr 2025 · 0 likes Post #122 answers the question as asked. The question underneath it is different. Objections are genuinely wanted at this stage, because a bad promotion is much harder…
-
Sequence verification for an obscure compound: how it is done Replied, post #10 · Compounds › Other compounds · 11 Apr 2025 · 13 likes Anyone submitting an unusual compound for testing should tell the laboratory what it is rather than what it is sold as. Method selection depends on the structure and…
-
Counter-ion content and its effect on measured mass Replied, post #14 · Analytics › Mass spectrometry · 9 Apr 2025 · 15 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
-
Carryover and the ghost peak from last week's standard Replied, post #44 · Analytics › HPLC & UHPLC · 6 Apr 2025 · 8 likes Post #40 and I disagree about the size of the effect, not about the direction. Gradient delay volume differs between instruments and shifts the whole chromatogram. It…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #51 · Compounds › Semaglutide · 24 Mar 2025 · 12 likes The confident answers on SELECT and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #148 · Sourcing › Vendor reports · 19 Mar 2025 · 0 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
When "no data" is the complete and final answer Replied, post #90 · Compounds › Other compounds · 11 Feb 2025 · 18 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Reading a supplementary appendix and finding the interesting part Replied, post #86 · Evidence › Trials · 6 Feb 2025 · 26 likes Discontinuation handling is the methodological detail that most changes a result and gets the least attention. Read how missing data was imputed before reading the…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #48 · Evidence › Meta-analyses · 3 Feb 2025 · 30 likes Individual participant data pooling is a much stronger design than aggregate pooling and is rare because it requires cooperation rather than a search.
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #3 · Compounds › Semaglutide · 2 Feb 2025 · 0 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
-
Scheduled maintenance and what will be unavailable Replied, post #24 · Meta › Announcements · 25 Jan 2025 · 0 likes Post #21 is right about the mechanism and I think understates the practical bit. Worth saying publicly: stepping back cleanly and handing over is a service. Documents…
-
Recovery when intake is low: what to cut first Replied, post #31 · Nutrition & Training › Resistance training · 11 Jan 2025 · 0 likes Picking up post #28: that is the part I would want checked first. The failure mode on recovery is boring rather than dramatic. It is almost always the step everyone…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #11 · Practice › Reconstitution · 10 Jan 2025 · 0 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #34 · Compounds › Oral incretins · 9 Jan 2025 · 5 likes Worth separating two things that post #30 runs together. Research-use-only oral material is not a licensed tablet and there is no reason to assume it carries a…
-
Isotonicity and what happens when you get it wrong Replied, post #22 · Pharmacology › Formulation chemistry · 9 Jan 2025 · 0 likes Post #18 describes the usual case. This is about the unusual one. Overfill in a vial is deliberate and accounts for the volume unrecoverable at the end. It is not…
-
Body image changing more slowly than the body Replied, post #136 · Wellbeing › Mental health · 26 Dec 2024 · 13 likes Body image and weight loss: large weight loss changes a person's relationship with their body in ways that can be psychologically complex. Some of that is positive;…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #26 · Sourcing › Red flags · 13 Dec 2024 · 1 like Everything in post #24 holds. The case it does not cover is the one I have. Prices well below the rest of the market are a fact rather than a finding. They are worth…
-
Body image changing more slowly than the body Replied, post #22 · Wellbeing › Mental health · 13 Dec 2024 · 25 likes Distinguishing three things in the body image discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation that…
-
What we do not know about retatrutide, listed explicitly Replied, post #15 · Compounds › Retatrutide · 8 Dec 2024 · 23 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #67 · Clinical › Special populations · 25 Nov 2024 · 6 likes Being outside the studied population does not mean a treatment is unsafe. It means the usual evidence is not available and the reasoning has to be explicit.
-
Why "any advice?" is the least effective ending for a post Replied, post #62 · Start Here › How to Ask · 22 Nov 2024 · 10 likes Bookmarking this. I will come back when I have something worth adding.
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #87 · Compounds › Repair & healing peptides · 18 Nov 2024 · 0 likes Reading a preclinical wound-healing model was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #10 · Nutrition & Training › Protein & intake · 18 Nov 2024 · 0 likes Post #8 describes the usual case. This is about the unusual one. Temperature and texture change what is tolerable for a lot of people during the first weeks, and that…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #8 · Analytics › Mass spectrometry · 18 Nov 2024 · 0 likes Response in electrospray is not proportional to abundance across different species. Using peak intensities from a mass spectrum to estimate proportions is a mistake…
-
Why our vendor pages link the storefront and mark it sponsored Replied, post #13 · Sourcing › Vendor reports · 11 Nov 2024 · 24 likes Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one. Our vendor pages deliberately mix services for that…
-
Time to steady state after a dose increase Replied, post #80 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 28 likes Narrowing post #78, because the general version has more than one answer. Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding…
-
Time to steady state after a dose increase Replied, post #47 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 0 likes Picking up post #46: that is the part I would want checked first. The accumulation ratio for weekly dosing with a week-long half-life is around two, which is why the…
-
Revisiting: Five questions in one post gets you one answer — how to split them Replied, post #5 · marked as the solution · Start Here › How to Ask · 21 Oct 2024 · 7 likes Worth separating two things that the opening post runs together. If your question has a deadline — a parcel in transit, a delivery you have to accept or refuse — say…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #119 · Access › Shortages · 13 Oct 2024 · 9 likes On post #118 — agreed on the reasoning, with one qualification. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #13 · Compounds › Retatrutide · 1 Sep 2024 · 0 likes I read post #9 twice before replying, because I had assumed the opposite. An observation about hepatic effects of glucagon receptor that I cannot explain and am posting…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #29 · Compounds › Semaglutide · 31 Aug 2024 · 11 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Circumference measurements as a poor man's composition estimate Replied, post #84 · Outcomes › Body composition · 21 Aug 2024 · 0 likes Worth separating two things that post #82 runs together. What would change my mind on circumference measurements is a second dataset collected by someone with no stake…
-
Circumference measurements as a poor man's composition estimate Replied, post #65 · Outcomes › Body composition · 14 Aug 2024 · 13 likes Taking post #62 at face value and following it one step further. Adding a null result on circumference measurements. I looked, carefully, and found nothing, and null…
-
Assessing a warm arrival: the decision process — one year on Replied, post #125 · Sourcing › Logistics · 2 Jun 2024 · 4 likes Understood, and I withdraw the assumption I opened with.
-
Assessing a warm arrival: the decision process — one year on Replied, post #118 · Sourcing › Logistics · 2 Jun 2024 · 0 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance. It is the sort of thing that seems obvious in…